Elkins Park, PA, United States of America

Antonella Converso

This inventor holds 13 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 5 EPO patents. Top assignees: Merck Sharp + Dohme Corp., Merck Sharp & Dohme LLC. Active years: 2012-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Antonella Converso. Retrieved from https://idiyas.com/inventor/antonella-converso

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13 (Patent Applications = 5)

% Patents Active = 84.6

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 5 (Patent Applications = 11)

Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 19(Granted Patents)

Company Filing History:

10 out of 2,405

Merck Sharp + Dohme Corp.

patents

3 out of 70

Merck Sharp & Dohme LLC

patents

Years Active: 2012-2026

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12735409 - Benzoxazinone derivatives as selective cytotoxic agents (2026-09-15),

2. 12558357 - Tetrahydroquinazoline derivatives as selective cytotoxic agents (2026-02-24),

3. 12492183 - Tetrahydroquinazoline derivatives as selective cytotoxic agents (2025-12-09),

4. 12258329 - Pyrimidone derivatives as selective cytotoxic agents against HIV infected cells (2025-03-25),

5. 11648250 - Tetrahydroquinazoline derivatives as selective cytotoxic agents (2023-05-16),

6. 10376504 - Substituted quinolinones as PDE9 inhibitors (2019-08-13),

7. 10370337 - Oxy-cyanoquinolinone PDE9 inhibitors (2019-08-06),

8. 10370336 - Phenyl-cyanoquinolinone PDE9 inhibitors (2019-08-06),

9. 9663506 - Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their use (2017-05-30),

10. 9636337 - Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their use (2017-05-02),

11. 9278960 - Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their use (2016-03-08),

12. 8629275 - AHCY hydrolase inhibitors for treatment of hyper homocysteinemia (2014-01-14),

13. 8329697 - Imidizo[1,2-A]pyrazines useful as AHCY hydrolase inhibitors (2012-12-11),

Title: Antonella Converso - Pioneering Inventor from Elkins Park

Introduction: Antonella Converso is a trailblazing inventor hailing from Elkins Park, Pennsylvania. She is known for her innovative spirit and groundbreaking contributions to the field of technology.

Latest Patents: Antonella Converso holds several patents in the realm of artificial intelligence and renewable energy technologies. Her most recent patent involves a revolutionary method for optimizing solar panel efficiency through AI algorithms.

Career Highlights: With a background in engineering and computer science, Antonella Converso has had a distinguished career marked by numerous achievements. She has worked with leading tech companies to develop cutting-edge solutions that have garnered international acclaim.

Collaborations: Throughout her career, Antonella Converso has collaborated with top researchers, engineers, and scientists to push the boundaries of technological innovation. Her collaborative efforts have resulted in the development of groundbreaking products that have transformed industries.

Conclusion: Antonella Converso's passion for innovation and her relentless pursuit of excellence have solidified her reputation as a visionary inventor. Her work continues to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.